pubmed.ncbi.nlm.nih.gov

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer - PubMed

Review

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Ranjeeta Thapa et al. Stem Cells Int. 2016.

Abstract

CD44 is a cell surface HA-binding glycoprotein that is overexpressed to some extent by almost all tumors of epithelial origin and plays an important role in tumor initiation and metastasis. CD44 is a compelling marker for cancer stem cells of many solid malignancies. In addition, interaction of HA and CD44 promotes EGFR-mediated pathways, consequently leading to tumor cell growth, tumor cell migration, and chemotherapy resistance in solid cancers. Accumulating evidence indicates that major HA-CD44 signaling pathways involve a specific variant of CD44 isoforms; however, the particular variant almost certainly depends on the type of tumor cell and the stage of the cancer progression. Research to date suggests use of monoclonal antibodies against different CD44 variant isoforms and targeted inhibition of HA/CD44-mediated signaling combined with conventional radio/chemotherapy may be the most favorable therapeutic strategy for future treatments of advanced stage malignancies. Thus, this paper briefly focuses on the association of the major CD44 variant isoforms in cancer progression, the role of HA-CD44 interaction in oncogenic pathways, and strategies to target CD44-overexpressed tumor cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1

The plot shows (a) CD44 gene and (b) protein structure. Figure is adapted from Louderbough and Schroeder, 2011 [161].

Figure 2
Figure 2

The influence of tumor cell produced by hyaluronan on cell signaling cascades. Figure is adapted from Toole, 2009 [78].

Similar articles

Cited by

References

    1. Bryne M., Boysen M., Alfsen C. G., et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Research. 1998;18(6):4757–4764. - PubMed
    1. Tang D. G. Understanding cancer stem cell heterogeneity and plasticity. Cell Research. 2012;22(3):457–472. doi: 10.1038/cr.2012.13. - DOI - PMC - PubMed
    1. Reya T., Morrison S. J., Clarke M. F., Weissman I. L. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111. doi: 10.1038/35102167. - DOI - PubMed
    1. Tammi R. H., Kultti A., Kosma V.-M., Pirinen R., Auvinen P., Tammi M. I. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Seminars in Cancer Biology. 2008;18(4):288–295. doi: 10.1016/j.semcancer.2008.03.005. - DOI - PubMed
    1. Colombatti A., Hughes E. N., Taylor B. A., August J. T. Gene for a major cell surface glycoprotein of mouse macrophages and other phagocytic cells is on chromosome 2. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences. 1982;79(6):1926–1929. - PMC - PubMed

Publication types